| Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline CL Daley, JM Iaccarino, C Lange, E Cambau, RJ Wallace Jr, C Andrejak, ... Clinical Infectious Diseases 71 (4), e1-e36, 2020 | 1154 | 2020 |
| Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, LF Anderson, ... The Lancet 392 (10150), 821-834, 2018 | 518 | 2018 |
| Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort L Guglielmetti, D Le Dû, M Jachym, B Henry, D Martin, E Caumes, ... Clinical Infectious Diseases 60 (2), 188-194, 2015 | 206 | 2015 |
| Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis Z Lan, N Ahmad, P Baghaei, L Barkane, A Benedetti, SK Brode, ... The Lancet Respiratory Medicine 8 (4), 383-394, 2020 | 194 | 2020 |
| Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement J Van Ingen, T Aksamit, C Andrejak, EC Böttger, E Cambau, CL Daley, ... European Respiratory Journal 51 (3), 2018 | 187 | 2018 |
| Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis L Guglielmetti, M Jaspard, D Le Dû, M Lachâtre, D Marigot-Outtandy, ... European Respiratory Journal 49 (3), 2017 | 160 | 2017 |
| Outcomes of bedaquiline treatment in patients with multidrug-resistant tuberculosis L Mbuagbaw, L Guglielmetti, C Hewison, N Bakare, M Bastard, E Caumes, ... Emerging infectious diseases 25 (5), 936, 2019 | 106 | 2019 |
| Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors N Veziris, C Bernard, L Guglielmetti, D Le Du, D Marigot-Outtandy, ... European Respiratory Journal 49 (3), 2017 | 97 | 2017 |
| Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment F Mougari, L Guglielmetti, L Raskine, I Sermet-Gaudelus, N Veziris, ... Expert review of anti-infective therapy 14 (12), 1139-1154, 2016 | 88 | 2016 |
| Management of patients with multidrug-resistant tuberculosis C Lange, RE Aarnoutse, JWC Alffenaar, G Bothamley, F Brinkmann, ... The international journal of tuberculosis and lung disease 23 (6), 645-662, 2019 | 83 | 2019 |
| Limited benefit of the new shorter multidrug-resistant tuberculosis regimen in Europe C Lange, R Duarte, M Fréchet-Jachym, G Guenther, L Guglielmetti, ... American journal of respiratory and critical care medicine 194 (8), 1029-1031, 2016 | 83 | 2016 |
| Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis K Dheda, KC Chang, L Guglielmetti, J Furin, HS Schaaf, D Chesov, ... Clinical Microbiology and Infection 23 (3), 131-140, 2017 | 79 | 2017 |
| Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases C Lange, EC Böttger, E Cambau, DE Griffith, L Guglielmetti, J van Ingen, ... The Lancet Infectious Diseases 22 (7), e178-e190, 2022 | 53 | 2022 |
| QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study L Guglielmetti, S Tiberi, M Burman, H Kunst, C Wejse, T Togonidze, ... European Respiratory Journal 52 (2), 2018 | 53 | 2018 |
| Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey M Amicosante, L D’Ambrosio, M Munoz, FCQ Mello, M Tebruegge, ... Jornal Brasileiro de Pneumologia 43, 380-392, 2017 | 51 | 2017 |
| Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries L Guglielmetti, C Hewison, Z Avaliani, J Hughes, N Kiria, N Lomtadze, ... The International Journal of Tuberculosis and Lung Disease 21 (2), 167-174, 2017 | 51 | 2017 |
| Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists’ point of view L Guglielmetti, F Mougari, A Lopes, L Raskine, E Cambau Future Microbiology 10 (9), 1467-1483, 2015 | 48 | 2015 |
| Safety and efficacy of exposure to bedaquiline− delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia L Guglielmetti, L Barkane, D Le Dû, D Marigot-Outtandy, J Robert, ... European Respiratory Journal 51 (3), 2018 | 43 | 2018 |
| False-negative interferon-γ release assay results in active tuberculosis: a TBNET study V De Visser, G Sotgiu, C Lange, MG Aabye, M Bakker, F Bartalesi, K Brat, ... European Respiratory Journal 45 (1), 279-283, 2015 | 39 | 2015 |
| Pregnancy in patients with tuberculosis: a TBNET cross-sectional survey GH Bothamley, C Ehlers, I Salonka, A Skrahina, A Orcau, LR Codecasa, ... BMC pregnancy and childbirth 16, 1-5, 2016 | 37 | 2016 |
